These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8094311)

  • 1. Neuroleptic malignant syndrome and ECT.
    Vallance H; McConachie I
    Br J Hosp Med; 1993 Jan 6-19; 49(1):50. PubMed ID: 8094311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anesthetic management for electroconvulsive therapy using target-controlled infusion of propofol].
    Imashuku Y; Kitagawa H; Kojima A; Ishikawa Y; Kuzukawa A; Nosaka S
    Masui; 2008 Jul; 57(7):889-91. PubMed ID: 18649646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anesthetic management for electroconvulsive therapy in the patients with a history of neuroleptic malignant syndrome].
    Setoyama K; Hirata T; Saeki H; Morimoto Y; Tsuruta S; Matsumoto M; Sakabe T
    Masui; 2009 May; 58(5):633-6. PubMed ID: 19462806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECT during and after the neuroleptic malignant syndrome: case report.
    Hughes JR
    J Clin Psychiatry; 1986 Jan; 47(1):42-3. PubMed ID: 3941060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anesthetic management for electroconvulsive therapy (ECT) in a patient with primary aldosteronism].
    Tezuka M; Kimura Y; Nagao M; Wake K; Takanishi T; Hamaguchi S; Okuda Y; Kitajima T
    Masui; 2003 May; 52(5):519-20. PubMed ID: 12795135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol safely used in a neuroleptic malignant syndrome patient.
    Rupreht J; Verkaaik AP; Erdmann W
    Anaesthesiol Reanim; 1991; 16(5):329-32. PubMed ID: 1741906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coma following ECT and intravenous droperidol: case report.
    Koo JY; Chien CP
    J Clin Psychiatry; 1986 Feb; 47(2):94-5. PubMed ID: 3944073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthetic management of electroconvulsive therapy in a patient with a known history of neuroleptic malignant syndrome.
    Kato N; Asakura Y; Mizutani M; Kandatsu N; Fujiwara Y; Komatsu T
    J Anesth; 2007; 21(4):527-8. PubMed ID: 18008129
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeated propofol anesthesia for a patient with a history of neuroleptic malignant syndrome.
    Sakamoto A; Hoshino T; Suzuki H; Kimura M; Ogawa R
    Nihon Ika Daigaku Zasshi; 1999 Aug; 66(4):262-5. PubMed ID: 10466342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial infarction: an unusual complication of neuroleptic malignant syndrome.
    Becker D; Birger M; Samuel E; Floru S
    J Nerv Ment Dis; 1988 Jun; 176(6):377-8. PubMed ID: 3373202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple ECT late in the course of neuroleptic malignant syndrome.
    McKinney P; Kellner C
    Convuls Ther; 1997 Dec; 13(4):269-73. PubMed ID: 9437570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy.
    Nisijima K; Oyafuso K; Shimada T; Hosino H; Ishiguro T
    Biol Psychiatry; 1996 Mar; 39(5):383-4. PubMed ID: 8704073
    [No Abstract]   [Full Text] [Related]  

  • 15. ECT in patients with major depressive disorder and low cardiac output.
    Stern L; Hirschmann S; Grunhaus L
    Convuls Ther; 1997 Jun; 13(2):68-73. PubMed ID: 9253526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bispectral index monitoring during anesthesia with propofol for electroconvulsive therapy].
    Umeda E; Nakai T; Satoh T; Kazama T
    Masui; 2004 Jul; 53(7):810-2. PubMed ID: 15298254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of electroconvulsive therapy in patients with asthma.
    Mueller PS; Schak KM; Barnes RD; Rasmussen KG
    Neth J Med; 2006 Dec; 64(11):417-21. PubMed ID: 17179572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families.
    Hermesh H; Aizenberg D; Lapidot M; Munitz H
    Am J Psychiatry; 1988 Nov; 145(11):1431-4. PubMed ID: 3189603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased propofol requirement during succeeding administrations for electroconvulsive therapy.
    Cohen Y; Feldinger E; Ogorek D; Weinbroum AA
    J Clin Anesth; 2004 Jun; 16(4):282-5. PubMed ID: 15261320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined alfentanil-methohexital anesthesia in electroconvulsive therapy.
    Dinwiddie SH; Isenberg KE
    Convuls Ther; 1995 Sep; 11(3):170-6. PubMed ID: 8528658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.